Entrepreneur Your Startup – Get a Master’s Degree
January 22, 2021
Calling all life sciences early stage founders and startups!
In partnership with the Lassonde Entrepreneur Institute at the University of Utah, the University’s David Eccles School of Business is now accepting applications to join its Master of Business Creation (MBC) program for 2021-2022. The priority application deadline is Feb. 12, 2021.
This nine-month, professional-degree program comes will a full scholarship. Those admitted spend 9 months working full-time launching and scaling their companies with help from faculty, mentors, grants, and more. The exceptional program is ranked among the top 10 in the nation.
The MBC degree has courses, workshops, and labs specifically designed for aspiring entrepreneurs to gain the knowledge and skills needed to create and scale their business. Entrepreneurs will work full-time on their companies, take entrepreneurially focused classes, engage in practicum labs, and receive personalized support. Faculty and mentors in the program are leading scholars and experienced entrepreneurs who can provide detailed insight into all stages of the startup process.
The MBC is comprised of required courses, integrated practicum courses and program workshops featuring special topics sessions over two semesters.
For more information, view below resources about the MBC.
- MBC homepage
- MBC overview video
- MBC founder profile video
- Register for upcoming virtual Q&A sessions
- Read about the 2020-21 MBC founders
Recent News
- BioUtah’s 2026 Utah Life Sciences Summit Recap
- 2026 Life Sciences Awards to be Presented at the Mayer Brown Utah Life Sciences Summit
- PROGRESS TRIAL DEMONSTRATES EDWARDS TAVR IS SUPERIOR TO CLINICAL SURVEILLANCE FOR MODERATE AS PATIENTS WITH AT-RISK FEATURES
- Denali Therapeutics Receives 2026 Prix Galien USA Award for AVLAYAH® (tividenofusp alfa-eknm) as Best Biotechnology Product
- Utah Business, Government Leaders Deepen Connections in Ireland
- Co-Diagnostics’ Joint Venture CoSara Diagnostics Announces Publication of Peer-Reviewed HPV Screening Study Using CoSara’s SARAGENE® Test
